Clinical Trial Update: Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study [Phase 2, Phase 3]

View source ↗

Summary

A pilot study evaluating once-weekly secnidazole granules for suppressive antibacterial therapy to prevent recurrent bacterial vaginosis has completed Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• secnidazole granules (secnidazole)

Snippet

Sponsor: Indiana University | Conditions: Recurrent Bacterial Vaginosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-02-05